Novis Pharmaceuticals Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
51
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
Novis Pharmaceuticals General Information
Description
Provider of biotherapeutic products. The company's products include plasma-derived products, such as albumin, immune globulin, hyper immunes and anti-hemophilic factors VII, VIII, and IX. Its biotherapeutics are used by hospitals, home infusion therapy companies and other health care providers to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders and other life-threatening conditions.
Contact Information
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 5000 Southwest 75th Avenue
- Suite 121
- Miami, FL 33155
- United States
Novis Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novis Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Novis Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novis Pharmaceuticals Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bio Med Plus | 10-Apr-2007 | 0000000000 | Distributors/Wholesale |